Zinaida Tigay

735 total citations · 1 hit paper
12 papers, 372 citations indexed

About

Zinaida Tigay is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Zinaida Tigay has authored 12 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Zinaida Tigay's work include Tuberculosis Research and Epidemiology (11 papers), Pneumonia and Respiratory Infections (3 papers) and Infectious Diseases and Tuberculosis (2 papers). Zinaida Tigay is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Pneumonia and Respiratory Infections (3 papers) and Infectious Diseases and Tuberculosis (2 papers). Zinaida Tigay collaborates with scholars based in United Kingdom, Uzbekistan and Australia. Zinaida Tigay's co-authors include Philipp du Cros, Nargiza Parpieva, Stobdan Kalon, Bern-Thomas Nyang’wa, Melvin Spigelman, Helen Cox, Sabine Rüsch–Gerdes, Varvara Solodovnikova, Irina Liverko and Matthew Dodd and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zinaida Tigay

11 papers receiving 359 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

2022 154 citations Bern-Thomas Nyang’wa, Catherine Berry et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Zinaida Tigay

Since Specialization

Citations

This map shows the geographic impact of Zinaida Tigay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zinaida Tigay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zinaida Tigay more than expected).

Fields of papers citing papers by Zinaida Tigay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zinaida Tigay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zinaida Tigay. The network helps show where Zinaida Tigay may publish in the future.

Co-authorship network of co-authors of Zinaida Tigay

This figure shows the co-authorship network connecting the top 25 collaborators of Zinaida Tigay. A scholar is included among the top collaborators of Zinaida Tigay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zinaida Tigay. Zinaida Tigay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Michael L. Rekart, (unknown), Gene L. Bidwell, (unknown), (unknown), Zinaida Tigay, Nargiza Parpieva, (unknown), (unknown), Diego E. Gómez, Andrew I. Mikhail, Animesh A. Sinha	2
2	A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis breakdown → 2022 ·New England Journal of Medicine ·Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis, Ilaria Motta, Nargiza Parpieva, Zinaida Tigay, Varvara Solodovnikova, Irina Liverko, Ronelle Moodliar, Matthew Dodd, Nosipho Ngubane, Mohammed Rassool, Timothy D. McHugh, Melvin Spigelman, David Moore, Koert Ritmeijer, Philipp du Cros, Katherine Fielding	154
3	Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan 2021 ·Trials ·Alexandra Wharton–Smith, Shona Horter, (unknown), (unknown), Nicola James, Bern-Thomas Nyang’wa, (unknown), (unknown), Zinaida Tigay, Emil Kazounis, (unknown), Beverley Stringer	0
4	Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan 2020 ·ERJ Open Research ·Philipp du Cros, (unknown), Zinaida Tigay, (unknown), Jane Greig, Graham Cooke, (unknown), (unknown), Catherine Berry, (unknown), D. Lister, Sebastian Dietrich, Cono Ariti, (unknown), Bern-Thomas Nyang’wa, Nargiza Parpieva, (unknown), Jay Achar	13
5	Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan 2020 ·PLoS ONE ·Shona Horter, Jay Achar, (unknown), Nargiza Parpieva, Zinaida Tigay, (unknown), Beverley Stringer	2
6	Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan 2020 ·BMC Infectious Diseases ·Shona Horter, Beverley Stringer, (unknown), Nargiza Parpieva, (unknown), Zinaida Tigay, (unknown), Jay Achar	13
7	Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan 2018 ·The International Journal of Tuberculosis and Lung Disease ·(unknown), Chris Smith, (unknown), Zinaida Tigay, Nargiza Parpieva, (unknown), Jay Achar, Jan Hájek, Jane Greig, Philipp du Cros, David Moore	8
8	Comparing shorter with conventional MDR-TB treatment in Uzbekistan: 2-month culture-conversion rates and treatment outcomes 2017 ·Faculty of 1000 Research Ltd ·Philipp du Cros, (unknown), D. Lister, (unknown), Catherine Berry, Jane Greig, Nargiza Parpieva, (unknown), Graham Cooke, Sebastian Dietrich, (unknown), Zinaida Tigay, Jay Achar	1
9	Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan 2016 ·BMC Infectious Diseases ·Shona Horter, Beverley Stringer, Jane Greig, (unknown), (unknown), Nargiza Parpieva, Zinaida Tigay, Philipp du Cros	24
10	Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study 2014 ·BMC Infectious Diseases ·(unknown), (unknown), (unknown), Zinaida Tigay, (unknown), Jurjen Duintjer Tebbens, Jiřı́ Vlček	37
11	Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis 2013 ·PLoS ONE ·Maeve K. Lalor, Jane Greig, (unknown), Sandy Althomsons, Zinaida Tigay, (unknown), (unknown), (unknown), Philipp du Cros	33
12	Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures 2007 ·PLoS ONE ·Helen Cox, Stobdan Kalon, (unknown), (unknown), Zinaida Tigay, Sabine Rüsch–Gerdes, (unknown), (unknown), (unknown)	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact